These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36034756)

  • 1. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway.
    Zhang X; Tian C; Cheng J; Mao W; Li M; Chen M
    Exp Ther Med; 2022 Sep; 24(3):563. PubMed ID: 36034756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
    Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Immune Infiltration and the Potential Biomarkers in Diabetic Peripheral Neuropathy through Bioinformatics and Machine Learning Methods.
    Li W; Guo J; Chen J; Yao H; Mao R; Li C; Zhang G; Chen Z; Xu X; Wang C
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 6. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy.
    Feng D; Shi X; Xiong Q; Zhang F; Li D; Wei W; Yang L
    Front Cell Dev Biol; 2022; 10():803766. PubMed ID: 35223835
    [No Abstract]   [Full Text] [Related]  

  • 7. The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.
    Song Z; Huang Y; Zhao Y; Ruan H; Yang H; Cao Q; Liu D; Zhang X; Chen K
    J Cancer; 2019; 10(6):1398-1408. PubMed ID: 31031850
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
    Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
    Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer.
    Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H
    PeerJ; 2023; 11():e15013. PubMed ID: 37070095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis.
    Liang X; Wang Y; Pei L; Tan X; Dong C
    Front Surg; 2022; 9():856446. PubMed ID: 35372462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of immune-related hub genes based on machine learning in prostate cancer and AOX1 is an oxidative stress-related biomarker.
    Mo X; Yuan K; Hu D; Huang C; Luo J; Liu H; Li Y
    Front Oncol; 2023; 13():1179212. PubMed ID: 37583929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer.
    Yu Z; Chao H; Xu F; Deng H; Deng L; Song Z; Zeng T
    Front Oncol; 2023; 13():1115718. PubMed ID: 37077837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer.
    Kang W; Ye C; Yang Y; Lou YR; Zhao M; Wang Z; Gao Y
    Front Pharmacol; 2024; 15():1383304. PubMed ID: 38957390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway.
    Liu F; Liang Y; Sun R; Yang W; Liang Z; Gu J; Zhao F; Tang D
    Chin Med; 2022 Aug; 17(1):91. PubMed ID: 35922850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of TREM2 promotes EMT via the PI3K/AKT pathway in gastric cancer: bioinformatics analysis and experimental verification.
    Li C; Hou X; Yuan S; Zhang Y; Yuan W; Liu X; Li J; Wang Y; Guan Q; Zhou Y
    J Cancer; 2021; 12(11):3277-3290. PubMed ID: 33976737
    [No Abstract]   [Full Text] [Related]  

  • 17. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cell differentiation trajectory-related gene signature to reveal the prognostic significance and immune landscape in prostate cancer based on multiomics analysis.
    Sun L; Tuo Z; Chen X; Wang H; Lyu Z; Li G
    Heliyon; 2024 Mar; 10(6):e27628. PubMed ID: 38510027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment.
    Sun JX; An Y; Xiang JC; Xu JZ; Hu J; Wang SG; Xia QD
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.